Stocks and Investing Stocks and Investing
Mon, August 7, 2023

Vikram Purohit Reiterated (ASND) at Hold and Held Target at $109 on, Aug 7th, 2023


Published on 2024-10-28 05:38:26 - WOPRAI, Vikram Purohit
  Print publication without navigation


Vikram Purohit of Morgan Stanley, Reiterated "Ascendis Pharma A/S" (ASND) at Hold and Held Target at $109 on, Aug 7th, 2023.

Vikram has made no other calls on ASND in the last 4 months.



There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 1 agrees with Vikram's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tiago Fauth of "Credit Suisse" Initiated at Hold and Held Target at $89 on, Wednesday, June 14th, 2023


These are the ratings of the 2 analyists that currently disagree with Vikram


  • Andreas Argyrides of "Wedbush" Reiterated at Buy and Held Target at $187 on, Wednesday, June 7th, 2023
  • Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $152 on, Thursday, June 1st, 2023

Contributing Sources